| Nov 25 | Feb 26 | May 26 | Aug 26 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Buy | — | — | — | — | — | — | — | 1 | — | — | — | — |
| Sell | 2 | 2 | 1 | 4 | 9 | 4 | 6 | 5 | — | 12 | 16 | 1 |
| total | individual payouts | |
|---|---|---|
| 2028 | ‡‡‡‡‡ |
|
| 2027 | ‡‡‡‡‡ |
|
| 2026 | 1.27 |
—
—
—
|
| 2025 | 1.08 |
—
—
—
—
|
| 2024 | 1.00 |
—
—
—
—
|
| 2023 | 1.00 |
—
—
—
—
|
| 2022 | 0.84 |
—
—
—
—
|
| 2021 | 0.72 |
—
—
—
—
|
| 2020 | 0.72 |
—
—
—
—
|
| 2019 | 0.68 |
—
—
—
—
|
| 2018 | 0.46 |
—
—
—
—
|
| 2017 | 0.32 |
—
—
—
—
|
| 2016 | 0.34 |
—
—
—
—
—
|
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Cash | 75,173.00 | 80,304.00 | 88,961.00 | 73,591.00 |
| Receivables | 112,433.00 | 133,029.00 | 169,805.00 | 211,848.00 |
| Inventory | — | — | — | — |
| Other | — | — | — | — |
| 187,606.00 | 213,333.00 | 258,766.00 | 285,439.00 |
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Payables | 91,434.00 | 114,895.00 | 142,030.00 | 167,794.00 |
| ST’ Debt | — | — | — | — |
| Other | 316,353.00 | 275,821.00 | 257,597.00 | 250,182.00 |
| 426,092.00 | 409,040.00 | 419,371.00 | 444,450.00 |
| 10y | 5y | 3y | |
| Sales | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Cash Flow | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Earnings | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Book Value | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 6,482.00 | 7,072.00 | — | — |
—
|
| ’25 | 5,599.00 | 5,851.00 | 6,135.00 | 6,336.00 |
23,921.00
|
| ’24 | 4,740.00 | 4,690.00 | 4,847.00 | 5,329.00 |
19,606.00
|
| ’23 | 5,116.00 | 4,656.00 | 4,606.00 | 4,459.00 |
18,837.00
|
| ’22 | 4,672.00 | 5,093.00 | 5,500.00 | 5,497.00 |
20,762.00
|
| ’21 | 4,715.00 | 4,527.00 | 4,570.00 | 4,708.00 |
18,520.00
|
| ’20 | 2,617.00 | 2,450.00 | 2,448.00 | 4,176.00 |
11,691.00
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 7,342.00 | 4,300.00 | — | — |
—
|
| ’25 | 6,359.00 | 3,177.00 | 538.00 | (763.00) |
9,311.00
|
| ’24 | (1,349.00) | (4,252.00) | 19,098.00 | (10,827.00) |
2,670.00
|
| ’23 | 9,777.00 | (5,216.00) | (5,011.00) | 20,037.00 |
19,587.00
|
| ’22 | 3,053.00 | (7,943.00) | 9,054.00 | (2,107.00) |
2,057.00
|
| ’21 | (4,742.00) | (594.00) | 1,815.00 | 5,639.00 |
2,118.00
|
| ’20 | 10,118.00 | (16,443.00) | (80.00) | 13,257.00 |
6,852.00
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 7,202.00 | 4,115.00 | — | — |
—
|
| ’25 | 6,242.00 | 3,049.00 | 393.00 | (921.00) |
8,763.00
|
| ’24 | (1,498.00) | (4,341.00) | 18,970.00 | (11,081.00) |
2,050.00
|
| ’23 | 9,618.00 | (5,455.00) | (5,250.00) | 19,974.00 |
18,887.00
|
| ’22 | 2,757.00 | (8,184.00) | 8,822.00 | (2,309.00) |
1,086.00
|
| ’21 | (4,928.00) | (833.00) | 1,637.00 | 5,326.00 |
1,202.00
|
| ’20 | 9,962.00 | (16,622.00) | (210.00) | 13,091.00 |
6,221.00
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 1.37 | 1.54 | — | — |
—
|
| ’25 | 0.99 | 1.08 | 1.26 | 1.33 |
4.65
|
| ’24 | 0.68 | 0.66 | 0.71 | 0.94 |
2.99
|
| ’23 | 0.83 | 0.64 | 0.56 | 0.51 |
2.54
|
| ’22 | 0.67 | 0.87 | 0.99 | 0.97 |
3.50
|
| ’21 | 0.73 | 0.59 | 0.74 | 0.76 |
2.83
|
| ’20 | 0.58 | 0.48 | 0.48 | 0.57 |
2.12
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | 59.35 | 45.00 | 59.67 | 65.88 | — | — | — |
Low Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 96.24 | 86.63 | 83.35 | 102.28 | — | — | — |
High Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 35,300 | 33,000 | 32,100 | 33,000 | — | — | — |
Employees
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.59 | 0.57 | 0.61 | 0.72 | — | — | — |
Revenue/Emp
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 20,762.00 | 18,837.00 | 19,606.00 | 23,921.00 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue
|
| ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡ | 100.00% | 100.00% | 100.00% | 100.00% | — | — | — |
Gross Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 9,388.00 | 6,378.00 | 7,692.00 | 11,459.00 | — | — | — |
EBT
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 45.22% | 33.86% | 39.23% | 47.90% | ‡‡‡ | ‡‡‡ | ‡‡‡ |
EBT Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 7,183.00 | 5,067.00 | 5,942.00 | 8,852.00 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Net Income
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2,623.00 | 2,168.00 | 2,241.00 | 2,057.00 | — | — | — |
Depreciation
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 11.01 | 10.33 | 10.73 | 13.26 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue/Sh
|
| ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | 3.52 | 2.55 | 3.00 | 4.67 | ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Earnings/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.09 | 10.74 | 1.46 | 5.16 | — | — | — |
Cash Flow/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (0.52) | (0.38) | (0.34) | (0.30) | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Capex/Sh
|
| ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.58 | 10.35 | 1.12 | 4.86 | — | — | — |
Free CF/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 19.42 | 22.46 | 26.46 | 27.40 | — | — | — |
Book Value/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1,885.00 | 1,824.00 | 1,828.00 | 1,804.00 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Shares
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 23.28 | 27.10 | 24.67 | 21.35 | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ |
PE Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 7.44 | 6.69 | 6.90 | 7.53 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PS Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 5.74 | 3.97 | 3.45 | 4.22 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PB Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 5.31 | 4.49 | 4.33 | 5.06 | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ |
EV/Sales
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 101.49 | 4.48 | 41.45 | 13.81 | — | — | — |
EV/FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2,057.00 | 19,587.00 | 2,670.00 | 9,311.00 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Op' Cash Flow
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (971.00) | (700.00) | (620.00) | (548.00) | ‡‡‡‡‡ | ‡‡‡‡‡ | — |
Capex
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1,086.00 | 18,887.00 | 2,050.00 | 8,763.00 | — | — | — |
FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (304,062.00) | (238,486.00) | (195,707.00) | (160,605.00) | — | — | — |
Working Cap'
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 38,941.00 | 26,128.00 | 22,428.00 | 22,199.00 | — | — | — |
Total Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (44,237.00) | (49,045.00) | (57,876.00) | (66,762.00) | — | — | — |
Net Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 36,608.00 | 40,958.00 | 48,375.00 | 49,425.00 | — | — | — |
Sh' Equity
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.09% | 0.89% | 1.13% | 1.73% | — | — | — |
ROA
|
| ‡‡‡ | ‡‡‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡ | 0.00% | 0.00% | 0.00% | 0.00% | — | — | — |
ROIC
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 18.13% | 15.85% | 15.44% | 20.57% | — | — | — |
ROE
|
Charles Schwab (SCHW) has transformed from a discount broker into a financial juggernaut, with revenue surging from $7.5 billion in 2016 to a projected $28.8 billion by 2027—a remarkable 285% decade-long climb fueled by the transformative 2020 TD Ameritrade acquisition. This $26 billion deal expanded client accounts to over 34 million and assets to $8 trillion, though integration hurdles like 2023 trading outages and tech migrations tested resilience amid rising rates and volatility. Profitability has rebounded sharply, with EPS forecasted to leap from $3.00 in 2024 to $6.52 by 2027, supported by a fortress balance sheet featuring negative net debt of -$57.9 billion and robust 15% ROE.
Yet, caution flags wave brightly: persistent insider selling totaling over $274 million in the past year—with zero buys—contrasts sharply with gleaming fundamentals and analyst targets implying 30% average upside from recent levels. Forward multiples look attractive at 16x PE by 2026, with revenue growth accelerating via net interest recovery and advisor services, but risks from regulatory scrutiny, competition, and execution on AI/crypto loom large.
Schwab’s narrative echoes historical merger marathons—explosive potential post-consolidation, tempered by human elements like insider profit-taking. Fundamentals scream undervaluation for patient investors, but watch for buyback signals amid sector shifts; the full analysis unpacks if this resilient giant reclaims $90+ highs.
Keep track of companies that you follow and research.
Full access to our data with predictions and indicators that we calculate daily.
Full access to our screener with tons of custom values and customizable email notifications.
Excel export of financials and screeners you define and save.